首页> 美国卫生研究院文献>other >Design synthesis and potent cytotoxic activity of novel 7-(N-(substituted-sulfonyl)piperazinyl-methyl)-camptothecin derivatives
【2h】

Design synthesis and potent cytotoxic activity of novel 7-(N-(substituted-sulfonyl)piperazinyl-methyl)-camptothecin derivatives

机译:新型7-(N-(取代-磺酰基)哌嗪基-甲基)喜树碱衍生物的设计合成和强细胞毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In an effort to discover potent camptothecin-derived antitumor agents, novel camptothecin analogues with sulfonylpiperazinyl motifs at position-7 were designed and synthesized. They were evaluated for in vitro cytotoxicity with the sulforhodamine-B (SRB) method in five types of human tumor cell lines, A-549, MDA-MB-231, KB, KB-VIN and MCF-7. With IC50 values in the low μM to nM level, most of the new analogues showed greater cytotoxicity activity than the reference compounds irinotecan and topotecan. Furthermore, compounds >12l (IC50, 1.2 nM) and >12k (IC50, 20.2 nM) displayed the highest cytotoxicity against the multidrug-resistant (MDR) KB-VIN cell line and merit further development as preclinical drug candidates for treating cancer, including MDR phenotype. Our study suggested that integration of sulfonylpiperazinyl motifs into position-7 of camptothecin is an effective strategy for discovering new potent cytotoxic camptothecin derivatives.
机译:为了发现有效的喜树碱衍生抗肿瘤药,设计并合成了在7位具有磺酰基哌嗪基基序的新型喜树碱类似物。用磺基罗丹明-B(SRB)方法评估了它们在五种类型的人类肿瘤细胞系A-549,MDA-MB-231,KB,​​KB-VIN和MCF-7中的体外细胞毒性。由于IC50值处于低至μM至nM的水平,大多数新的类似物显示出比参考化合物伊立替康和托泊替康更大的细胞毒性。此外,化合物> 12l (IC50,1.2 nM)和> 12k (IC50,20.2 nM)对多药耐药(MDR)KB-VIN细胞系和作为治疗包括MDR表型在内的癌症的临床前候选药物,值得进一步发展。我们的研究表明,将磺酰基哌嗪基基序整合到喜树碱的7位是发现新的有效的细胞毒性喜树碱衍生物的有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号